Reply to ‘Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumour response and tolerance’ by Funck-Brentano et al.
Titel:
Reply to ‘Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumour response and tolerance’ by Funck-Brentano et al.
Auteur:
Goldwirt, L. Chami, I. Feugeas, J.-P. Pages, C. Brunet-Possenti, F. Allayous, C. Baroudjian, B. Madelaine, I. Sauvageon, H. Mourah, S. Lebbé, C.